General anaesthesia with aerosol box during COVID pandemic

Completed

• Conditions: Neoplasms,

• Registration Number: CTRI/2020/07/026610
• Lead Sponsor: Cancer Institute WIA

Brief Summary

Tracheal intubation performed during general anaesthesia is an aerosol generating procedure placing the anaesthesia team at risk for contracting corona virus. The aerosol box is a containment device recommended for use and widely being used during intubation to protect the anaesthesia team and the surroundings. There is no scientific study regarding the ease of intubation and problems faced while using the aerosol box as well as patient safety during the intubation process. Hence we are planning to do a prospective study of intubation related outcomes and patient safety during intubation while using the aerosol box.

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-04-09
• Study Start: 2020-07-28
• Last Update Posted: 2022-07-20

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• 1.Age: Patients of both sexes greater than or equal to 18 yrs of age 2.Patients receiving suxamethonium or rocuronium (if allergic to suxamethonium or contraindication to suxamethonium) will be included.
• 3.Intubations performed by anaesthesiologists who have ≥ 3 years clinical experience following their training will be considered for the study.
• 4.Anaesthesiologists will use the conventional Macintosh Laryngoscope or the C-Mac Video Laryngoscope depending upon the availability and comfort.

Exclusion Criteria

• 1.Patients requiring awake fiberoptic guided intubation.
• 2.Patients who cannot fit within the aerosol box due to their body habitus.
• 3.Patients who are undergoing emergency surgery and are at risk for gastric aspiration.
• 4.Patients requiring double lumen tube (DLT) insertion.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to intubation- defined as time from when the laryngoscope blade passes between the patients lips until the first upstroke of the capnograph trace	24 hours

Secondary Outcome Measures

Name	Time	Method
1.Airway manipulation time	2.The number of attempts made to intubate.

Trial Locations

Locations (1)

Cancer Institute (WIA); 🇮🇳 Chennai, TAMIL NADU, India

Cancer Institute (WIA)

🇮🇳Chennai, TAMIL NADU, India

DrMeenakshi V V

Principal investigator

9940370735

meenaram99@yahoo.com